Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002002041 | SCV002207733 | likely benign | Nemaline myopathy 2 | 2023-08-05 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV003134270 | SCV003813552 | uncertain significance | not provided | 2019-01-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004042951 | SCV004979525 | uncertain significance | Inborn genetic diseases | 2024-02-28 | criteria provided, single submitter | clinical testing | The c.6664A>G (p.M2222V) alteration is located in exon 50 (coding exon 48) of the NEB gene. This alteration results from a A to G substitution at nucleotide position 6664, causing the methionine (M) at amino acid position 2222 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |